WatchIPO GMP Live Today

WatchIPO GMP provides the latest Live IPO Grey Market Premium (GMP) rates, Kostak rates, and Subject to Sauda (SS) figures for all Mainline and SME IP

Thursday, December 11, 2025

Top IPOs December 2025: Park Medi, Shipwaves & Ashwini GMP Status | WatchIPO

Top IPOs December 2025: Park Medi, Shipwaves & Ashwini GMP Status | WatchIPO

Top IPOs to Watch in December 2025: Park Medi World, Shipwaves & Ashwini Container Analysis

Last Updated: December 11, 2025 | By Abhijeet | Category: Market Analysis

The Indian primary market is witnessing a flurry of activity as we close out 2025. While many investors are still tracking the post-listing performance of November giants, three specific Initial Public Offerings (IPOs) are currently grabbing headlines: Park Medi World, Shipwaves Online, and Ashwini Container Movers.

At WatchIPO GMP, we cut through the noise to bring you the raw data, the Grey Market Premium (GMP) trends, and a clear verdict on whether these issues are worth your capital.

1. Park Medi World (Mainboard IPO)

Park Medi World is the heavyweight of the week. As a Mainboard IPO, it naturally attracts more institutional interest compared to its SME counterparts. The company operates in the healthcare sector, which has seen resilient growth this year.

Issue Details

Parameter Details
Open Date Dec 10, 2025
Close Date Dec 12, 2025
Price Band ₹154 to ₹162 per share
Lot Size 92 Shares

GMP & Listing Analysis

As of December 11, the GMP for Park Medi World is hovering around ₹22 - ₹26. This translates to an estimated listing gain of roughly 13-16% against the upper price band of ₹162.

While this isn't a "multibagger" signal, it indicates a stable listing. Investors should look at the subscription numbers for QIB (Qualified Institutional Buyers) on the final day (Dec 12) before making a decision.

2. Shipwaves Online (SME IPO)

This is arguably the most interesting play for risk-takers this week. Shipwaves Online is an SME IPO listed on the BSE. The company is involved in the digital logistics space, a sector that is rapidly digitizing in India.

Why is everyone talking about it?

The price point is incredibly low at a fixed price of ₹12 per share. Low-ticket IPOs often attract massive retail volume due to the psychological perception of "affordability."

GMP Trend

The Grey Market is signaling strong demand here. The current GMP is approximately ₹4 per share. While ₹4 sounds small, on a base price of ₹12, that is a massive 33% premium.

Note: SME IPOs are high-risk. While the percentage gain looks attractive, liquidity on listing day can be an issue. Always check the risks of SME investing before bidding.

3. Ashwini Container Movers (SME IPO)

Opening on December 12, 2025, Ashwini Container Movers is another logistics player entering the NSE SME platform.

Issue Details

  • Price Band: ₹135 - ₹142
  • Issue Size: Approx ₹71 Crores
  • Closing Date: Dec 16, 2025

Current Sentiment

Unlike Shipwaves, the sentiment here is currently muted. The GMP is trading at a marginal ₹6 - ₹7 (approx 4-5%). This suggests that the market is taking a "wait and watch" approach. We recommend tracking the subscription levels on Day 1 before blocking your funds here.

Quick Comparison: Where Should You Invest?

Here is a quick snapshot to help you decide:

Company Category Est. Premium Risk Level
Park Medi World Mainboard ~15% Low-Medium
Shipwaves Online SME ~33% High
Ashwini Container SME ~4% High

Conclusion

If you are looking for safety, Park Medi World offers a decent entry point into the healthcare sector with a modest listing pop. However, for those with a higher risk appetite seeking percentage gains, Shipwaves Online is the clear winner in the Grey Market currently.

For official filings and Red Herring Prospectus (RHP) documents, always verify with the SEBI official website or the respective exchange websites (NSE / BSE).

Disclaimer: The content provided on WatchIPO GMP is for informational purposes only. GMP (Grey Market Premium) is an unofficial figure and can change rapidly. This is not financial advice. Please consult your financial advisor before investing.

Wednesday, December 10, 2025

Corona Remedies IPO Allotment Status, GMP Today & Listing Gain Review

The wait is finally over for investors! Today, December 11, 2025, is the official Basis of Allotment date for the Corona Remedies IPO. After a strong response from QIBs and NIIs during the subscription period, all eyes are now on the allotment status and the surging Grey Market Premium (GMP).

In this detailed update, we cover the latest GMP as of today, step-by-step instructions to check your allotment status on Bigshare Services, and the calculated listing price based on current market trends.

🚀 Quick Status Check (Dec 11)

  • Allotment Status: Expected Today
  • Latest GMP: ₹291 per share (Up from ₹270)
  • Listing Gain: ~27.40%

📊 Check Live GMP Dashboard

Corona Remedies IPO GMP Today (December 11, 2025)

The Grey Market sentiment has strengthened significantly today. Despite market volatility, Corona Remedies is commanding a premium of nearly ₹300.

Metric Value
GMP Today ₹291 per share
IPO Price Band ₹1,062 per share
Est. Listing Price ₹1,353 (₹1,062 + ₹291)
Percentage Gain 27.40%
Subject to Sauda (SS) ₹3,100 per Retail Lot

How to Check Corona Remedies IPO Allotment Status?

Since Bigshare Services is the official registrar for this issue, you must check your status on their portal. Follow these steps:

Method 1: Via Bigshare Services Website

  1. Go to the Bigshare IPO Allotment Page.
  2. Select any one of the servers (Server 1, 2, or 3).
  3. In the "Company Selection" dropdown, look for "Corona Remedies Limited". (Note: If the name is not there, the allotment is not yet live. Keep refreshing.)
  4. Select "PAN Number" as your selection type.
  5. Enter your PAN and the Captcha code.
  6. Click "Search." Your allotment details will be displayed on the screen.

Method 2: Via BSE Website

  1. Visit the BSE IPO Application Status page.
  2. Under "Issue Type," select Equity.
  3. Under "Issue Name," select Corona Remedies Limited.
  4. Enter your Application Number or PAN.
  5. Click "Search."

Subscription Analysis: Why the GMP is Rising

The GMP uptick to ₹291 is driven by the strong subscription numbers seen on the final day.

  • QIB (Qualified Institutional Buyers): Subscribed heavily, signaling long-term confidence in the pharma sector.
  • NII (HNI Category): Saw oversubscription of 60.90x, creating a "scarcity premium" in the grey market.
  • Retail: Subscribed 10.30x, making allotment tough for small investors.

Financial Health Snapshot

Before the listing on December 15, let's recap the fundamentals that are driving this price.

Financial Metric FY 2025 Figure
Revenue ₹1,196 Crores
Net Profit (PAT) ₹149.43 Crores
EBITDA ₹246 Crores
P/E Valuation ~43x (Fairly Valued)

Listing Strategy: Hold or Sell?

With a 27-30% listing gain likely, here is a strategy for different investors:

  • For Listing Gain Players: If the stock lists above ₹1,350, it is a good opportunity to book partial profits. The grey market has priced in most of the upside.
  • For Long-Term Investors: Corona Remedies operates in high-growth chronic therapy areas (Women's Health, Cardiac). If you get an allotment, holding for the medium term (6-12 months) could yield better returns as the company utilizes its cash flow for expansion.

Disclaimer: The GMP prices quoted here are based on market rumors and are for educational purposes only. We are not SEBI-registered advisors. Please consult your financial advisor before investing.

Live GMP Dashboard

Understanding the Buzz: Your Guide to IPOs and Grey Market Trends

Investing in the stock market often starts with the excitement of an Initial Public Offering (IPO). An IPO represents the first opportunity for the public to buy shares in a privately held company, transitioning it into a publicly traded entity. This is where primary market investment begins, offering a chance for significant listing day gains.

Key IPO Metrics for Investors

When a company launches its IPO, investors monitor several key metrics to predict its success:

  • **Subscription Status:** The demand for the IPO across different investor categories (QIB, NII, Retail) is a strong indicator of market confidence. High over-subscription often correlates with positive listing outcomes.
  • **Issue Price & Price Band:** This is the range at which the company is offering its shares. The final issue price, usually the upper band, is the starting point for calculating all potential returns.
  • **Anchor Investors:** The presence of large, credible institutions (Anchor Investors) often validates the quality of the IPO and boosts investor sentiment.

Before the shares even list on the BSE or NSE, the informal **Grey Market Premium (GMP)** provides the most immediate signal of investor anticipation. We focus purely on delivering the most up-to-date figures to help you make informed pre-listing decisions.